- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06870591
Pivotal Study for the Cardiac Performance System (CPS)
April 21, 2026 updated by: Sensydia Corporation
Pivotal Method-Comparison Study for the Cardiac Performance System (CPS) to Measure Hemodynamic Parameters
This multi-center, observational study evaluates the accuracy of the Cardiac Performance System (CPS), a non-invasive device, for measuring hemodynamic parameters in adult patients undergoing clinically indicated right heart catheterization.
The study compares CPS measurements to invasive measurements to assess agreement and potential clinical utility.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The study will enroll adults undergoing right heart catheterization as part of their clinical care.
A single CPS measurement will be performed before the scheduled procedure.
Data from both CPS and catheterization measurements will be analyzed to assess agreement.
No investigational treatment or additional follow-up visits are required.
Study Type
Observational
Enrollment (Estimated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Huntsville, Alabama, United States, 35801
- Recruiting
- Huntsville Hospital Heart Center
-
Contact:
- Principal Investigator
- Phone Number: 256-519-8472
- Email: csullivan@theheartcenter.md
-
-
Illinois
-
Evanston, Illinois, United States, 60201
- Recruiting
- Endeavor Health
-
Contact:
- Principal Investigator
- Phone Number: 847-570-2250
- Email: clinicaltrials@northshore.org
-
-
New Jersey
-
Hackensack, New Jersey, United States, 07601
- Recruiting
- Hackensack University Medical Center
-
Contact:
- Principal Investigator
- Phone Number: 551-996-2255
- Email: ora@hmhn.org
-
Neptune City, New Jersey, United States, 07753
- Recruiting
- Jersey Shore University Medical Center
-
Contact:
- Principal Investigator
- Phone Number: 551-996-2255
- Email: ora@hmhn.org
-
-
New York
-
New York, New York, United States, 10032
- Recruiting
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
-
Contact:
- Principal Investigator
- Phone Number: 212-305-5064
- Email: ctoinformation@columbia.edu
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Recruiting
- The Ohio State University Medical Center
-
Contact:
- Principal Investigator
- Phone Number: 614-685-4619
- Email: cardiovascular.research@osumc.edu
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Recruiting
- University of Pennsylvania - Penn Presbyterian Medical Center
-
Contact:
- Principal Investigator
- Phone Number: 215-662-4484
- Email: psom-ocr@pobox.upenn.edu
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Recruiting
- Medical University of South Carolina
-
Contact:
- Principal Investigator
- Phone Number: 843-792-2300
- Email: musc-ocr@musc.edu
-
-
Tennessee
-
Germantown, Tennessee, United States, 38138
- Recruiting
- The Stern Cardiovascular Foundation, Inc. / Baptist Memorial Hospital
-
Contact:
- Principal Investigator
- Phone Number: 901-271-1000
- Email: sharon.goldstein@sterncardio.com
-
-
Texas
-
Houston, Texas, United States, 77030
- Recruiting
- Baylor College of Medicine
-
Contact:
- Principal Investigator
- Phone Number: 713-798-1297
- Email: ClinicalResearch@bcm.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The study population consists of adult patients aged 18 years and older who are scheduled to undergo clinically indicated right heart catheterization as part of their standard medical care.
Participants will represent a diverse range of individuals with conditions requiring invasive hemodynamic assessment.
Description
Inclusion Criteria:
- Adults aged 18 years or older
- Scheduled for clinically indicated right heart catheterization
- Ability to provide informed consent
Exclusion Criteria:
- Heart transplant recipients
- Patients with a left ventricular assist device (LVAD)
- Presence of external devices (e.g., Holter monitors) or surgical scars/wounds that interfere with CPS measurements
- Measurement concerns related to data reliability or quality
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
CPS Measurement Group
Participants undergoing clinically indicated right heart catheterization will receive a single, non-invasive measurement using the Cardiac Performance System (CPS) before their scheduled procedure.
The study aims to compare CPS results with standard invasive hemodynamic measurements.
|
CPS is a non-invasive platform for hemodynamic assessment that uses acoustic sensors and electrocardiogram electrodes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiac Performance System electronic data for Pulmonary Pressure
Time Frame: Single measurement prior to right heart catheterization
|
Cardiac function metric measurement including Pulmonary Pressure measured in mmHg
|
Single measurement prior to right heart catheterization
|
|
Pulmonary artery catheter electronic data for Pulmonary Pressure
Time Frame: During right heart catheterization procedure
|
Cardiac function metric measurement including Pulmonary Pressure measured in mmHg
|
During right heart catheterization procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 22, 2025
Primary Completion (Estimated)
April 30, 2026
Study Completion (Estimated)
May 30, 2026
Study Registration Dates
First Submitted
February 24, 2025
First Submitted That Met QC Criteria
March 5, 2025
First Posted (Actual)
March 11, 2025
Study Record Updates
Last Update Posted (Actual)
April 24, 2026
Last Update Submitted That Met QC Criteria
April 21, 2026
Last Verified
June 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CPS_PIVOTAL
Drug and device information, study documents
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Cardiac Performance System (CPS)
-
Stephen EsperSensydia CorporationCompletedHeart DiseasesUnited States
-
Sensydia CorporationUniversity of Pittsburgh Medical CenterCompleted
-
Sensydia CorporationRecruiting
-
Sensydia CorporationOrlando Health, Inc.Recruiting
-
Karlsburg HospitalRecruitingHemodynamic Monitoring | Cardiac Failure AcuteGermany
-
LabStyle Innovations Ltd.CompletedDiabetes MellitusUnited States
-
Medtronic Cardiac Rhythm and Heart FailureCompleted
-
Abbott Medical DevicesTerminated
-
Miami Research AssociatesGlanbia Performance NutritionCompleted
-
Qilu Hospital of Shandong UniversityRecruitingArtificial Intelligence | Endoscopy | Intestinal Metaplasia of Gastric MucosaChina